Graviton Bioscience
New York, NY
Graviton Bioscience is a clinical-stage drug discovery and development firm focused on creating and developing therapies for the treatment of CNS, autoimmune, fibrotic, and other significant disorders in which ROCK2 plays a critical role in pathology.
gravitoncorp.comCompany Details
Founded
- 2020
Employees
- Between 20 - 50 employees
Raised
- $64,819,496
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
Samuel Waksal
Company Collections
These are collections Graviton Bioscience is a part of. Click on the collection name to view similar companies.